Plasma neuropeptide Y levels differ in distinct diabetic conditions

Neuropeptides

Volumn 44, Issue 6, 2010, Pages 485-489

  Ilhan, Aysegül ^a   Rasul, Sazan ^a   Dimitrov, Alexander ^b   Handisurya, Ammon ^a   Gartner, Wolfgang ^a,c   Baumgartner Parzer, Sabina ^a   Wagner, Ludwig ^a   Kautzky Willer, Alexandra ^a   Base, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c St Vincent Hospital   (Austria)

Author keywords

Diabetes mellitus type 2 (DM2); Diabetic polyneuropathy (PNP); Gestational diabetes mellitus (GDM); Neuropeptide Y (NPY); Radioimmunoassay

Indexed keywords

GLUCOSE; NEUROPEPTIDE Y;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; FEMALE; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPEPTIDE Y; PREGNANCY; RADIOIMMUNOASSAY;

EID: 78349311147     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.08.001     Document Type: Article

References (34)

1. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in the rat brain. Science 1983, 221:877-879.
2. Bai F.L., Yamano M., Shiotani Y., Emson P.C., Smith A.D., Powell J.F., Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 1985, 331:172-175.
3. Baranowska B., Wolinska-Witort E., Wasilewska-Dziubinska E., Roguski K., Martynska L., Chmielowska M. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders. Neuro Endocrinol. Lett. 2003, 24:431-434.
4. Beck B., Stricker-Krongrad A., Nicolas J.P., Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 1992, 16:295-302.
5. Bernet F., Dedieu J.F., Laborie C., Montel V., Dupouy J.P. Circulating neuropeptide Y (NPY) and catecholamines in rat under resting and stress conditions Arguments for extra-adrenal origin of NPY, adrenal and extra-adrenal sources of catecholamines. Neurosci. Lett. 1998, 250:45-48.
6. Bi S. Role of dorsomedial hypothalamic neuropeptide Y in energy homeostasis. Peptides 2007, 28:352-356.
7. Bluher M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 2009, 117:241-250.
8. Burnand R.C., Price S.A., McElhaney M., Barker D., Tomlinson D.R. Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes. Brain Res. Mol. Brain Res. 2004, 132:235-240.
9. Cho Y.R., Kim C.W. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation. Biochem. Biophys. Res. Commun. 2004, 314:773-780.
10. Cox H.M. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton. Neurosci. 2007, 133:76-85.
11. de Luca C., Kowalski T.J., Zhang Y., Elmquist J.K., Lee C., Kilimann M.W., Ludwig T., Liu S.M., Chua S.C. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 2005, 115:3484-3493.
12. Ericsson A., Schalling M., McIntyre K.R., Lundberg J.M., Larhammar D., Seroogy K., Hokfelt T., Persson H. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc. Natl. Acad. Sci. USA 1987, 84:5585-5589.
13. Gray T.S., Morley J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 1986, 38:389-401.
14. Gulbenkian S., Wharton J., Hacker G.W., Varndell I.M., Bloom S.R., Polak J.M. Co-localization of neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON). Peptides 1985, 6:1237-1243.
15. Jacques D., Sader S., Perreault C., Abdel-Samad D., Provost C. Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function. Can. J. Physiol. Pharmacol. 2006, 84:695-705.
16. Kalra S.P., Kalra P.S. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 2004, 38:201-211.
17. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. USA 1991, 88:10931-10935.
18. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 1999, 20:68-100.
19. Kautzky-Willer A., Bancher-Todesca D. Gestational diabetes. Wien. Med. Wochenschr. 2003, 153:478-484.
20. Kos K., Harte A.L., James S., Snead D.R., O'Hare J.P., McTernan P.G., Kumar S. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1335-E1340.
21. Lin E.J., Sainsbury A., Lee N.J., Boey D., Couzens M., Enriquez R., Slack K., Bland R., During M.J., Herzog H. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology 2006, 147:5094-5101.
22. Milewicz A., Mikulski E., Bidzinska B. Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 2000, 24(Suppl. 2):S152-S153.
23. Ruohonen S.T., Pesonen U., Moritz N., Kaipio K., Roytta M., Koulu M., Savontaus E. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance. Diabetes 2008, 57:1517-1525.
24. Satoh C., Satoh F., Takahashi K., Murakami O., Sone M., Totsune K., Yabe T., Ohneda M., Fukuda M., Sugimura K., Ogawa S., Nagakubo H., Sato T., Mouri T. Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy. Endocr. J. 1999, 46:139-146.
25. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 1992, 13:387-414.
26. Sipols A.J., Baskin D.G., Schwartz M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 1995, 44:147-151.
27. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986, 7:1189-1192.
28. Sundkvist G., Bramnert M., Bergstrom B., Manhem P., Lilja B., Ahren B. Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction. Diabetes Res. Clin. Pract. 1992, 15:219-226.
29. Takiyyuddin M.A., Brown M.R., Dinh T.Q., Cervenka J.H., Braun S.D., Parmer R.J., Kennedy B., O'Connor D.T. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J. Auton. Pharmacol. 1994, 14:187-200.
30. Tallroth G., Ryding E., Ekman R., Agardh C.D. The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetes Res. 1992, 20:73-85.
31. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA 1982, 79:5485-5489.
32. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 296:659-660.
33. Yokosuka M., Xu B., Pu S., Kalra P.S., Kalra S.P. Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol. Behav. 1998, 64:331-338.
34. Zochodne D.W. Diabetic polyneuropathy: an update. Curr. Opin. Neurol. 2008, 21:527-533.